These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 305966)

  • 1. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. II. Correlation with BCG activity in syngeneic tumor systems.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1978 May; 60(5):1069-73. PubMed ID: 305966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of BCG on alloimmune cell-mediated cytotoxicity in (C57BL/6Jfemale x A/Jmale)F1 mice. I. Effect of different BCG treatments on cytotoxicity mediated by T-cells and macrophages.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1978 May; 60(5):1059-68. PubMed ID: 305965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different doses of BCG on an allogeneic cell-mediated antitumor response in mice.
    Davies M; Sabbadini E
    J Natl Cancer Inst; 1977 Jul; 59(1):263-5. PubMed ID: 875058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effects of different strains or batches of same strain of BCG on in vitro generation of syngeneic and allogeneic antitumor cytotoxicity.
    Mokyr MB; Bennett JA; Braun DP; Hengst JC; Mitchell MS; Dray S
    J Natl Cancer Inst; 1980 Feb; 64(2):339-44. PubMed ID: 6928226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of bacille Calmette-Guérin on the immune response of BALB/c mice to a tumor allograft.
    Treagan L; Chen TH; Rambo O; Elberg SS
    J Infect Dis; 1979 Oct; 140(4):541-5. PubMed ID: 117062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective mobilization of specifically cytotoxic T-lymphocytes at sites of inflammation in relation to BCG-induced resistance to implants of syngeneic sarcoma in mice.
    Parr IB; Wheeler E; Alexander P
    J Natl Cancer Inst; 1977 Dec; 59(6):1659-66. PubMed ID: 303704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent adjuvant effects of Bacillus Calmette-Guérin on tumor immunity in Lewis rats.
    Davies M; Sabbadini E
    Cancer Res; 1979 Mar; 39(3):959-65. PubMed ID: 311684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
    Taniguchi K; Gondo H; Nomoto K
    J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of anti-MOPC-315 cytotoxicity in uneducated or in vitro educated spleen cells from normal or MOPC-315 tumor-bearing mice pretreated in vivo with Bacillus Calmette-Guérin.
    Braun DP; Mokyr MB; Dray S
    Cancer Res; 1978 Jun; 38(6):1626-32. PubMed ID: 647676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences in the rejection of an allogeneic tumor graft in two strains of inbred mice and their F1 hybrids.
    Turianskyj FH; Gyenes L
    Immunol Commun; 1974; 3(6):565-75. PubMed ID: 4452575
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition or enhancement of rat mammary tumors dependent on dose BCG.
    Piessens WF; Campbell M; Churchill WH
    J Natl Cancer Inst; 1977 Jul; 59(1):207-11. PubMed ID: 875054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to weakly immunogenic virally induced tumors. I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross-reactive tumor.
    Galili N; Devens B; Naor D; Becker S; Klein E
    Eur J Immunol; 1978 Jan; 8(1):17-22. PubMed ID: 639838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
    Olsson L; Florentin I; Kiger N; Mathé G
    J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V; Lodillinsky C; Umerez S; Sandes E; Eiján AM
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16].
    Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV
    Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line.
    Pang AS; Morales A
    J Urol; 1982 Jun; 127(6):1225-9. PubMed ID: 7087042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.